South Korea · Delayed Price · Currency is KRW MEDICOX Statistics
Total Valuation
MEDICOX has a market cap or net worth of KRW 12.68 billion. The enterprise value is 20.33 billion.
| Market Cap | 12.68B |
| Enterprise Value | 20.33B |
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDICOX has 5.52 million shares outstanding. The number of shares has increased by 40.36% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +40.36% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.71 |
| EV / Sales | 0.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.83 |
Financial Position
The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.23.
| Current Ratio | 0.47 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.57 |
| Interest Coverage | -4.08 |
Financial Efficiency
Return on equity (ROE) is -23.90% and return on invested capital (ROIC) is -10.45%.
| Return on Equity (ROE) | -23.90% |
| Return on Assets (ROA) | -4.94% |
| Return on Invested Capital (ROIC) | -10.45% |
| Return on Capital Employed (ROCE) | -11.32% |
| Weighted Average Cost of Capital (WACC) | 7.10% |
| Revenue Per Employee | 454.21M |
| Profits Per Employee | -191.86M |
| Employee Count | 62 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 23.34 |
Taxes
In the past 12 months, MEDICOX has paid 129.76 million in taxes.
| Income Tax | 129.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.91% in the last 52 weeks. The beta is -0.03, so MEDICOX's price volatility has been lower than the market average.
| Beta (5Y) | -0.03 |
| 52-Week Price Change | -75.91% |
| 50-Day Moving Average | 2,911.20 |
| 200-Day Moving Average | 4,459.80 |
| Relative Strength Index (RSI) | 41.36 |
| Average Volume (20 Days) | 865,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MEDICOX had revenue of KRW 28.16 billion and -11.90 billion in losses. Loss per share was -2,209.00.
| Revenue | 28.16B |
| Gross Profit | 2.11B |
| Operating Income | -5.92B |
| Pretax Income | -11.77B |
| Net Income | -11.90B |
| EBITDA | -4.19B |
| EBIT | -5.92B |
| Loss Per Share | -2,209.00 |
Balance Sheet
The company has 3.49 billion in cash and 10.81 billion in debt, with a net cash position of -7.32 billion or -1,324.51 per share.
| Cash & Cash Equivalents | 3.49B |
| Total Debt | 10.81B |
| Net Cash | -7.32B |
| Net Cash Per Share | -1,324.51 |
| Equity (Book Value) | 47.11B |
| Book Value Per Share | n/a |
| Working Capital | -8.48B |
Cash Flow
In the last 12 months, operating cash flow was -3.43 billion and capital expenditures -774.02 million, giving a free cash flow of -4.21 billion.
| Operating Cash Flow | -3.43B |
| Capital Expenditures | -774.02M |
| Depreciation & Amortization | 1.73B |
| Net Borrowing | -10.36B |
| Free Cash Flow | -4.21B |
| FCF Per Share | -761.39 |
Margins
Gross margin is 7.50%, with operating and profit margins of -21.01% and -42.24%.
| Gross Margin | 7.50% |
| Operating Margin | -21.01% |
| Pretax Margin | -41.78% |
| Profit Margin | -42.24% |
| EBITDA Margin | -14.87% |
| EBIT Margin | -21.01% |
| FCF Margin | n/a |
Dividends & Yields
MEDICOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.36% |
| Shareholder Yield | -40.36% |
| Earnings Yield | -93.82% |
| FCF Yield | -33.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Nov 16, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MEDICOX has an Altman Z-Score of -0.92 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.92 |
| Piotroski F-Score | 3 |